PEN:NYSE
Penumbra Inc
၃၁၉.၄၀ US$
arrow_upward
+၀.၅၉%(+၁.၈၈) 1D
အောက် ၉, GMT-၄ ၁၆:၀၀:၀၄ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PEN...
Open
၃၁၇.၀၆ US$
High
၃၁၉.၅၃ US$
Low
၃၁၇.၀၆ US$
Mkt. cap
ဋေ ၁.၂၆ ထ
Avg. vol.
၃.၆၄ သိန်း
Volume
၅.၅၅ သိန်း
P/E ratio
၇၈.၄၅
52-wk high
၃၆၂.၄၁ US$
52-wk low
၂၂၁.၂၆ US$
EPS
၄.၀၇ US$
Beta
၀.၇၀
Shares outstanding
၃.၉၄ ကုဋေ
No. of employees
၅ ထောင်
Open
၃၁၇.၀၆ US$
High
၃၁၉.၅၃ US$
Low
၃၁၇.၀၆ US$
Mkt. cap
ဋေ ၁.၂၆ ထ
Avg. vol.
၃.၆၄ သိန်း
Volume
၅.၅၅ သိန်း
P/E ratio
၇၈.၄၅
52-wk high
၃၆၂.၄၁ US$
52-wk low
၂၂၁.၂၆ US$
EPS
၄.၀၇ US$
Beta
၀.၇၀
Shares outstanding
၃.၉၄ ကုဋေ
No. of employees
၅ ထောင်
News stories
From web sources and news partners
Simply Wall Street
·
ပြီးခဲ့သည့် ၁ ရက်
Will Wearable Recovery Data Change Penumbra Stock Narrative
www.dars.gov.et
·
ပြီးခဲ့သည့် ၁ ပတ်
Penumbra (PEN) Slips 0.11% to $318.0 as Shares Consolidate Below Resistance - Equal Weight ETF
AD HOC NEWS
·
ပြီးခဲ့သည့် ၂ လ
Penumbra presented STORM-PE data while Penumbra stock trades at EUR 281.30
Profile
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.
In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by year-end. Wikipedia
About Penumbra Inc